« Back

Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has secured an $18 million secured loan facility from Oxford Finance Corp. and CIT Healthcare. The company is currently in registration for an $86.25 million IPO, and has raised $78 million in VC funding from Domain Associates (23.2% pre-IPO stake), Clarus Ventures (23.1%), Scale Venture Partners (15.4%), Thomas McNerney & Partners (13.2%) and Abingworth Ventures (10%)

« Back